Multicenter Open Label Phase 2 Study of Quadruplet-Based Regimen Iskpd (isatuximab plus pomalidomide and dexamethasone with carfilzomib) in Early Relapsed or Refractory Multiple Myeloma-IFM2018-03Arthur Bobin,Jerome Lambert, Stefanie Ragot,Aurore Perrot,Salomon Manier,Lionel Karlin,Denis Caillot,Lotfi Benboubker,Thomas Chalopin,Carla Araujo,Jean Fontan,Thorsten Braun,Clara Mariette, Elodie Scherman,Olivier Decaux,Jean Sebastien Blade, Faiza Keddar,Christophe Roul,Mamoun Dib,Jill Corre, Frederique Orsini Piocelle, Laure Vincent, Cyrille Touzeau, Philippe Moreau, Herve Avet Loiseau, Xavier LeleuBLOOD（2023）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
